Vaxcyte (PCVX) News
NASDAQ: PCVXHealthcareBiotechnologyUSD
65.02-1.95 (-2.90%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PCVX news summary
We found 6 recent headlines mentioning Vaxcyte (PCVX): 6 in the past week and 6 in the past 30 days, most often from Nasdaq, Investor's Business Daily. For price context, PCVX is down 2.90% at $65.02. The most recent story, "Stocks Finish Higher on Lower Bond Yields and Earnings Optimism", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Vaxcyte headlines
- Stocks Finish Higher on Lower Bond Yields and Earnings OptimismThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.58% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.48%.…NasdaqALK, GOOGL, UAL, AMAT
- S&P 500 and Nasdaq 100 Post Record Highs as Crude Prices and Bond Yields FallThe S&P 500 Index ($SPX ) (SPY ) is up by +0.49% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. December E-mini S&P…NasdaqALK, UAL, SLB, GNTX
- Stocks Climb as Inflation Risks Ease and Bond Yields DeclineThe S&P 500 Index ($SPX ) (SPY ) is up by +0.75% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. December E-mini S&P…NasdaqALK, GOOGL, UAL, AAPL
- Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest LosersBiotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. The post Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The…Investor's Business DailyPCVX, MRNA
- Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.NasdaqCRL, HTFL, ILMN, INFU
- Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine StudyVaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from Pfizer and Merck. The post Vaxcyte Catapults After Going Toe-To-Toe With…Investor's Business DailyPCVX, PFE